Comparison of a Single Dose Fibrinogen With Placebo and the Number of Blood Transfusions After Ascending Aorta Surgery (FIBTEG Study)

Trial Profile

Comparison of a Single Dose Fibrinogen With Placebo and the Number of Blood Transfusions After Ascending Aorta Surgery (FIBTEG Study)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Aneurysm; Haemorrhage
  • Focus Therapeutic Use
  • Acronyms FIBTEG
  • Most Recent Events

    • 29 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Dec 2017.
    • 29 Mar 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2017.
    • 28 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top